Brain scan study tests Psychedelic's power against depression
NCT ID NCT06820723
Summary
This study aims to understand how a single dose of a drug related to psilocybin (the psychedelic compound in 'magic mushrooms') might help people with depression and anxiety. Researchers will give 40 participants either the drug or a placebo and use brain scans and questionnaires to measure changes in brain activity and symptoms. The main goal is to learn how the drug works in the brain, not to provide a cure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Ohio State University Department of Psychiatry
Columbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.